CVS Health Co. (NYSE:CVS) Shares Sold by Stansberry Asset Management LLC

Stansberry Asset Management LLC lowered its stake in shares of CVS Health Co. (NYSE:CVSFree Report) by 93.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,929 shares of the pharmacy operator’s stock after selling 161,004 shares during the quarter. Stansberry Asset Management LLC’s holdings in CVS Health were worth $750,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in CVS. CX Institutional boosted its holdings in CVS Health by 38.3% in the second quarter. CX Institutional now owns 9,350 shares of the pharmacy operator’s stock worth $552,000 after purchasing an additional 2,589 shares during the period. U.S. Capital Wealth Advisors LLC boosted its holdings in CVS Health by 2.2% in the second quarter. U.S. Capital Wealth Advisors LLC now owns 82,872 shares of the pharmacy operator’s stock worth $4,894,000 after purchasing an additional 1,757 shares during the period. BDF Gestion acquired a new position in CVS Health in the second quarter worth $2,897,000. OLD National Bancorp IN boosted its holdings in CVS Health by 6.2% in the second quarter. OLD National Bancorp IN now owns 276,562 shares of the pharmacy operator’s stock worth $16,334,000 after purchasing an additional 16,028 shares during the period. Finally, Capital Investment Advisors LLC boosted its holdings in CVS Health by 0.5% in the second quarter. Capital Investment Advisors LLC now owns 431,230 shares of the pharmacy operator’s stock worth $25,468,000 after purchasing an additional 2,058 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Down 1.9 %

Shares of CVS opened at $58.05 on Thursday. The business’s 50-day moving average price is $59.43 and its 200 day moving average price is $58.81. The stock has a market capitalization of $73.05 billion, a P/E ratio of 14.73, a P/E/G ratio of 1.01 and a beta of 0.54. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVSGet Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the previous year, the business posted $2.21 EPS. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. Analysts expect that CVS Health Co. will post 5.37 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.58%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analyst Weigh In

A number of research firms have commented on CVS. Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Truist Financial reiterated a “buy” rating and issued a $67.00 target price (down from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. Barclays cut their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Finally, TD Cowen raised their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $70.50.

Check Out Our Latest Stock Report on CVS Health

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.